Journal article
INFOGRAPHIC: 2-year efficacy, durability and safety of intravitreal faricimab with treat-and-extend dosing up to 16 weeks in diabetic macular oedema (pooled results from YOSEMITE and RHINE)
Authors
Wijesingha N; Gibson K; Willis JR; Sivaprasad S
Journal
Eye, Vol. 39, No. Suppl 1, pp. 167–169
Publisher
Springer Nature
Publication Date
February 1, 2025
DOI
10.1038/s41433-024-03249-0
ISSN
0950-222X